Development of an AIDS vaccine: a daunting epidemiological challenge.
Nathanson
Neal
N
Mathieson
Bonnie J
BJ
D016915:AIDS Vaccines / Q000276:immunology / Q000627:therapeutic use; D000163:Acquired Immunodeficiency Syndrome / Q000209:etiology / Q000276:immunology / Q000517:prevention & control / Q000821:virology; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D002986:Clinical Trials as Topic; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D005544:Forecasting; D006678:HIV / Q000276:immunology; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control; D015497:HIV-1 / Q000276:immunology; D015498:HIV-2 / Q000276:immunology; D000882:Haplorhini; D006801:Humans; D008297:Male; D009500:Neutralization Tests; D011323:Primates; D015302:Simian Immunodeficiency Virus / Q000276:immunology
D016915:AIDS Vaccines; D000914:Antibodies, Viral